Mizuna Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -4.57%
- Ebitda -4.57%
- Net Worth -2666.87%
- Total Assets -8.55%
About Mizuna Bio Sciences
Mizuna Bio Sciences Private Limited (MBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2015 (Nine years and six months 15 days old ). Its registered office is in Bidar, Karnataka, India.
The Corporate was formerly known as Vivimed Specialty Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Vydya and Tomar Vipin serve as directors at the Company.
Company Details
-
Location
Bidar, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100KA2015PTC081669
-
Company No.
081669
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jul 2015
-
Date of AGM
09 Jun 2023
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Mizuna Bio Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Vydya
|
Additional Director | 24-Mar-2023 | Current |
|
Tomar Vipin
|
Additional Director | 24-Mar-2023 | Current |
Financial Performance of Mizuna Bio Sciences.
Mizuna Bio Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2666.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mizuna Bio Sciences?
In 2022, Mizuna Bio Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
James Robinson Labs Private LimitedSanjay Vydya is a mutual person
-
Medentis Dental Solutions India Private LimitedTomar Vipin is a mutual person
-
Procon Power Tech Private LimitedSanjay Vydya is a mutual person
-
Viv Life Llp
Tomar Vipin is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mizuna Bio Sciences?
Unlock and access historical data on people associated with Mizuna Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mizuna Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mizuna Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
